Amir H Zamanipoor Najafabadi

24PUBLICATIONS
75CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)Multimorbidity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 13, 2026
The Dutch Prolactinoma Cohort Studies: Cross-sectional Analysis of Females Focusing on the Patient's Perspective.

|Sep 29, 2025
How to Define Success in Prolactinoma Treatment-A Systematic Review and Theoretical Framework.

Victoria R van Trigt, Kevin A Huynh, Leontine E H Bakker

|Jun 09, 2023
The prevalence and severity of fatigue in meningioma patients and its association with patient-, tumor- and treatment-related factors.

Kwong T Quach, Linda Dirven, Aliede M Vingerhoed

|Apr 14, 2023
The DEXA-CORT trial: study protocol of a randomised placebo-controlled trial of hydrocortisone in patients with brain tumour on the prevention of neuropsychiatric adverse effects caused by perioperative dexamethasone.

Anne-Sophie C A M Koning, Djaina D Satoer, Christiaan H Vinkers

|Jan 10, 2023
Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up.

Kevin A Huynh, Eva C Coopmans, Amir H Zamanipoor Najafabadi

|Nov 03, 2022
Starting point for benchmarking outcomes and reporting of pituitary adenoma surgery within the European Reference Network on Rare Endocrine Conditions (Endo-ERN): results from a meta-analysis and survey study.

Amir H Zamanipoor Najafabadi, Merel van der Meulen, Ana Luisa Priego Zurita

Pageof 4

Frequent Collaborators

12 joint publications

Wouter R van Furth

10 joint publications

Nienke R Biermasz

6 joint publications

Alberto M Pereira

5 joint publications

Linda Dirven